Because rMV-SLAMblind does not have an affinity for immune cells [19], rMV-SLAMblind likely reaches Nectin-4-expressing tumor cells by blood flow but not through the spread of the virus-infected immune cells. This evidence concerns the gene NECTIN4 and neoplasm.